Evidence map›Paper›PMID 24041011›Full record

ArticleRetrovirology2013

Ability of HIV-1 Nef to downregulate CD4 and HLA class I differs among viral subtypes.

Jaclyn K Mann, Helen Byakwaga, Xiaomei T Kuang, Anh Q Le, Chanson J Brumme, Philip Mwimanzi, Saleha Omarjee, Eric Martin, Guinevere Q Lee, Bemuluyigza Baraki and 12 more

Open access · goldAbstract read
In one paragraph

Article in Retrovirology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 61 papers.

0numbers the graph read from it
0cells of the map it votes in
61citing papers in PubMed
2.9field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

61 citing papers in PubMed, 85 citations in OpenAlex.

  1. Trial
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. HIV-1 subtypes maintain distinctive physicochemical signatures in Nef domains associated with immunoregulation.Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases · 2023
    Article
  15. Article
  16. Article
  17. Impact of HIV-1 subtypes on gross deletion in theJournal of ginseng research · 2022
    Article
  18. Article
  19. Article
  20. Article

1 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 9 institutions in 6 countries.

Jaclyn K MannDepartment of Molecular Biology and Biochemistry, Simon Fraser University, Burnaby, BC, Canada. mark_brockman@sfu.ca.
Helen Byakwaga
Xiaomei T Kuang
Anh Q Le
Chanson J Brumme
Philip Mwimanzi
Saleha Omarjee
Eric Martin
Guinevere Q Lee
Bemuluyigza Baraki
Ryan Danroth
Rosemary McCloskey
Conrad Muzoora
David R Bangsberg
Peter W Hunt
Philip J R Goulder
Bruce D Walker
P Richard Harrigan
Jeff N Martin
Thumbi Ndung'u
Mark A Brockman
Zabrina L Brumme
AIDS Vancouver · CASimon Fraser University · CAUniversity of California, San Francisco · USUniversity of KwaZulu-Natal · ZAHarvard University · USMassachusetts General Hospital · USMax Planck Institute for Infection Biology · DEMbarara University of Science and Technology · UGUniversity of Oxford · GB

Funding

Virology CoreP30AI027763 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI STEVEN Grant DEEKS · 1988 to 2026
$93.6M
TB PREVENTION AND HIV IN THE HOMELESS--AN INTERVENTIONR01MH054907 · NIMH · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI BANGSBERG, DAVID ROY · 1995 to 2014
$20.7M
CIHR HOP-115700CIHR MOP-93536NIAID NIH HHS P30 AI027763NIMH NIH HHS R01 MH054907
6 · The paper itself

Abstract

backgroundThe highly genetically diverse HIV-1 group M subtypes may differ in their biological properties. Nef is an important mediator of viral pathogenicity; however, to date, a comprehensive inter-subtype comparison of Nef in vitro function has not been undertaken. Here, we investigate two of Nef's most well-characterized activities, CD4 and HLA class I downregulation, for clones obtained from 360 chronic patients infected with HIV-1 subtypes A, B, C or D.

resultsSingle HIV-1 plasma RNA Nef clones were obtained from N=360 antiretroviral-naïve, chronically infected patients from Africa and North America: 96 (subtype A), 93 (B), 85 (C), and 86 (D). Nef clones were expressed by transfection in an immortalized CD4+ T-cell line. CD4 and HLA class I surface levels were assessed by flow cytometry. Nef expression was verified by Western blot. Subset analyses and multivariable linear regression were used to adjust for differences in age, sex and clinical parameters between cohorts. Consensus HIV-1 subtype B and C Nef sequences were synthesized and functionally assessed. Exploratory sequence analyses were performed to identify potential genotypic correlates of Nef function. Subtype B Nef clones displayed marginally greater CD4 downregulation activity (p = 0.03) and markedly greater HLA class I downregulation activity (p < 0.0001) than clones from other subtypes. Subtype C Nefs displayed the lowest in vitro functionality. Inter-subtype differences in HLA class I downregulation remained statistically significant after controlling for differences in age, sex, and clinical parameters (p < 0.0001). The synthesized consensus subtype B Nef showed higher activities compared to consensus C Nef, which was most pronounced in cells expressing lower protein levels. Nef clones exhibited substantial inter-subtype diversity: cohort consensus residues differed at 25% of codons, while a similar proportion of codons exhibited substantial inter-subtype differences in major variant frequency. These amino acids, along with others identified in intra-subtype analyses, represent candidates for mediating inter-subtype differences in Nef function.

conclusionsResults support a functional hierarchy of subtype B > A/D > C for Nef-mediated CD4 and HLA class I downregulation. The mechanisms underlying these differences and their relevance to HIV-1 pathogenicity merit further investigation.

Indexed as

Host-Pathogen InteractionsAdultAfricaCD4 AntigensCD4-Positive T-LymphocytesCell LineDown-RegulationFemaleGenotypeHistocompatibility Antigens Class IHIV-1HIV InfectionsHumansMalenef Gene Products, Human Immunodeficiency VirusNorth AmericaCD4 AntigensHistocompatibility Antigens Class Inef Gene Products, Human Immunodeficiency Virusnef protein, Human immunodeficiency virus 1

Identifiers

PMID24041011
PMCPMC3849644
OpenAlexW2110299975

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.